Promoter holding
64.27%
UL
Unijules Life Sciences Limited - Due diligence report
A 360° intelligence report on Unijules Life Sciences: trust score, financial health, credit view, compliance, directors, growth and distress…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Unijules Life Sciences — 360° Intelligence Report
Generated from MCA filings & public records36/100
Trust Score
Caution Indicated
Unijules Life Sciences is assessed as Caution Indicated with a Trust Score of 36/100. Unijules Life Sciences is an active public limited indian non-government company incorporated in 2006, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.
Report generated on 20 Jul 2026 from the latest processed filings. Unijules Life Sciences Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreCaution Indicated
36/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
5/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 4 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Liabilities ≈ 38% EBITDA - stretched.
- Externally credit-rated (D).
Charges position: 26 open (817.76 cr) · 3 satisfied (49.75 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Axis Bank Limited | 5 | 48.0 cr |
| State Bank Of India | 5 | 48.0 cr |
| Others | 4 | 48.0 cr |
| The Shamrao Vithal Co-Op. Bank Ltd. | 4 | 48.0 cr |
| Punjab National Bank | 1 | 48.0 cr |
| Bank Of Maharashtra | 1 | 48.0 cr |
Compliance Score: 5/100 Caution Indicated
- Company status is Active as per MCA.
- Marked ACTIVE non-compliant (INC-22A).
- Last balance sheet is for Mar 2018 - filings overdue.
- Flagged by authority: SEBI, MCA, NCLT.
- Litigation present in 5 court forum(s).
- 1 active GST registration(s).
Legal cases on record (5)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| Pawan Kumar Chokhani | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Pranav Pawan Chokhani | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Ankit Pawan Chokhani | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
Director & KMP remuneration (FY 2018)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2018 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Aritra Investment And Trading Private Limited | Associate Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 30
Growth signals & trust indicators
Operating for 20+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Negative net worth.
Statutory filings appear overdue.
Compliance score is weak (5/100).
26 open charge(s) registered - assets are encumbered.
5 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence22/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 4 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment23/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 26 open charge(s) of 817.76 cr already registered.
- Compliance gaps should be priced into terms.
Investor view27/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events01 Jan 2026
Director appointed
Pawan Kumar Chokhani (Director)
Director appointed
Pranav Pawan Chokhani (Director)
Director appointed
Ankit Pawan Chokhani (Director)
09 Jan 2019
Director ceased
HARPREET SINGH
30 Sep 2018
Last AGM held
Annual general meeting
31 Mar 2018
Latest balance sheet
Filed with ROC
30 Sep 2017
Director ceased
AMIT PRAVEEN CHHABRA
30 Sep 2016
Director ceased
HAKIMUDDIN NISARALI RIZVI
02 Jun 2016
Director ceased
RAJEEV KAWADUJI JIDEWAR
15 Apr 2014
Charge created
Others - 4.00 cr
01 Oct 2013
Director ceased
VAIBHAV SHANTARAM DESHPANDE
30 Sep 2013
Director ceased
GULAM ABBAS HASSONJEE
26 Mar 2013
Charge created
Punjab National Bank - 48.00 cr
30 Oct 2012
Director ceased
NARESH JANARDAN GAIKWAD
29 Sep 2012
Director ceased
AMIT ASHOK GUPTA
10
Key Observations
Auto-generated from the data aboveRevenue declined 1.42 over the last 3 financial year(s).
Net profit margin moved from 2.1x to 24%.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of D from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2018 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Breakeven Petrochemicals Private Limited | U24100UP2013PTC057274 | Noida, Uttar Pradesh, India |
| Vegan Colloids Limited | U74999HR1998PLC035357 | Haryana, Haryana, India |
| Acaricide India Private Limited | U24120TG1995PTC021775 | Hyderabad, Telangana, India |
| Kino Organics (India) Limited | U51109UP2004PLC087687 | Lucknow, Uttar Pradesh, India |
| Madaus Pharmaceuticals Private Limited | U24230TG1996PTC124476 | Hyderabad, Telangana, India |
| Medilux | U24232MP1985PTC002843 | Indore, Madhya Pradesh, India |
| Veda Biofuel Limited | U24100AP2010PLC070652 | Visakhapatnam, Andhra Pradesh, India |
| Makson Industries Private Limited | U24240MP2003PTC035109 | Mandideep, Madhya Pradesh, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Unijules Life Sciences before audits and certifications: compliance score 5/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Unijules Life Sciences: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Unijules Life Sciences - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 36/100, distress signals and MSME payment-delay disclosures - know whether Unijules Life Sciences pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (5 case(s) on record), regulatory flags, charge documents trail and director networks for Unijules Life Sciences - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Unijules Life Sciences an active company?
Unijules Life Sciences has MCA status “Active” with a compliance score of 5/100 (Caution Indicated).
Is Unijules Life Sciences financially healthy?
Unijules Life Sciences has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Unijules Life Sciences?
Its overall Trust Score is 36/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Unijules Life Sciences?
Promoters hold a majority stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Unijules Life Sciences have loans or charges against its assets?
26 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.
Is Unijules Life Sciences up to date with its ROC filings?
Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 5/100 (Caution Indicated).
Is it risky to lend to Unijules Life Sciences?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
